Torben Lund-Hansen

Insider Reports History

Location
New York, NY
Signature
/s/ John LaRocca, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Torben Lund-Hansen:

Company Role Class Num Shares Value Price $ Report Date Ownership
Y-mAbs Therapeutics, Inc. SVP & CHIEF TECHNICAL OFFICER Common Stock 45,662 $701,825 $15.37 28 Aug 2024 By Toluha ApS
Y-mAbs Therapeutics, Inc. SVP & CHIEF TECHNICAL OFFICER Common Stock 35,600 $547,172 $15.37 28 Aug 2024 Direct
Y-mAbs Therapeutics, Inc. SVP & CHIEF TECHNICAL OFFICER Employee Stock Option (right to buy) 100,000 28 Aug 2024 Direct
Y-mAbs Therapeutics, Inc. SVP & CHIEF TECHNICAL OFFICER Employee Stock Option (right to buy) 35,700 18 Jan 2024 Direct

Insider Reports Filed by Torben Lund-Hansen

Symbol Company Period Transactions Value $ Form Type Role Filing Time
YMAB Y-mAbs Therapeutics, Inc. 28 Aug 2024 3 -$549,500 4 SVP & CHIEF TECHNICAL OFFICER 30 Aug 2024, 16:15
YMAB Y-mAbs Therapeutics, Inc. 18 Jan 2024 2 $0 4 SVP & CHIEF TECHNICAL OFFICER 22 Jan 2024, 17:54
YMAB Y-mAbs Therapeutics, Inc. 26 Jan 2023 1 $0 4 SVP & CHIEF TECHNICAL OFFICER 30 Jan 2023, 15:34
YMAB Y-mAbs Therapeutics, Inc. 17 Jan 2023 2 $0 4 SVP & CHIEF TECHNICAL OFFICER 19 Jan 2023, 15:44
YMAB Y-mAbs Therapeutics, Inc. 26 Apr 2022 1 $0 4 SVP & CTO 28 Apr 2022, 18:21
YMAB Y-mAbs Therapeutics, Inc. 14 Dec 2021 1 $0 4 SVP & CTO 16 Dec 2021, 17:05